Mechanisms of aluminium neurotoxicity in oxidative stress-induced ...

Mechanisms of aluminium neurotoxicity in oxidative stress-induced ... Mechanisms of aluminium neurotoxicity in oxidative stress-induced ...

dspace.usc.es
from dspace.usc.es More from this publisher
28.11.2012 Views

SUMMARY values were attained at 48 hours post-injection for both TBARS and PCC, and at 24 hours for PTC. Interestingly, lower but significant increases in oxidative stress levels were also seen in the contralateral side (ventral midbrain and striatum) excluding this zone as a control to determine neurochemical alterations caused by 6-OHDA in this experimental model of PD. At last and according to the obtained results, we decided to establish the optimal time of 48 hours post-injection for quantification of brain oxidative stress indices when assessing the oxidative potential of aluminium in this experimental model of PD. 152 The second part of this thesis consisted in developing a dosage regimen of aluminium to rats which would guarantee a significant accumulation of this metal in brain areas and also to determine its precise distribution in the brain. As it was previously suggested that aluminium distribution depends on the animal species in question and the chemical form of aluminium administered, we opted for two distinct administration routes: oral and intraperitoneal. Sprague-Dawley rats were either daily i.p. injected with aluminium chloride (10 mg Al 3+ /kg/day) for 1 week, or given orally progressive increasing doses of aluminium chloride (25, 50, 100 mg Al 3+ /kg/day) supplemented with citrate (89, 178, 356 mg/kg/day) during 4 weeks. Our results showed that both administration routes led to aluminium accumulation. A greater and more significant increase was noted in the group receiving aluminium via intraperitoneal administration for most brain areas except in ventral midbrain. Distribution also varied with the administration route used. In accordance to these results we resolved to use the intraperitoneal administration route to clarify the brain oxidative stress provoked by aluminium. Finally the third phase of this thesis was dedicated to determine the ability of aluminium to alter the oxidant status of specific brain areas, such as cerebellum, ventral midbrain, cortex, hippocampus, and striatum. Male Sprague-Dawley rats were intraperitoneally administered with aluminium chloride (10 mg Al 3+ /kg/day) in saline for 10 days. As we demonstrated before, this dosage procedure was sufficient to insure aluminium accumulation in brain areas. Animals were sacrificed 48 hours after lesion to perform lipid peroxidation and protein oxidation studies because the peak for oxidative

SUMMARY stress is reached at this time as we previously reported in the first phase of this thesis. Our results showed that, except for hippocampus, the metal triggered an increase in oxidative stress levels (determined as TBARS, PCC, and PTC) for most of the brain regions studied, which was accompanied by decreased activities of the antioxidant enzymes (SOD, CAT, and GPx). However, studies in vitro confirmed the inability of aluminium to affect the activity of those enzymes and also of MAO-A and MAO-B. The reported effects exhibited a regional-selective behaviour for all the cerebral structures studied. Worthy of note is the case of the hippocampus, as aluminium exposure resulted in increased antioxidant enzymes activities, no significant alterations of lipid peroxidation and decreased protein oxidations. These results might be explained by the high aluminium accumulation and the promotion of compensatory mechanism(s) in this brain area. Lastly, and to shed some light on the potential of aluminium to act as an etiological factor in PD, we studied the ability of this metal to increase the striatal DAergic neurodegeneration and various indices of oxidative stress in ventral midbrain and striatum of rats injected intraventricularly with 6-OHDA. This animal model was known to induce a more slowly ensuing parkinsonian syndrome exhibiting similar topographic depletion of DAergic neurons to that observed in PD (Rodriguez et al. 2001, Rodríguez-Díaz et al. 2001) and to avoid the focal lesion around the cannula tip produced when 6-OHDA is directly injected in the brain tissues. We followed the same dosage procedure as previously mentioned (daily intraperitoneal injection of 10 mg mg Al 3+ /kg/day in saline for ten days) except that rats were lesioned on the 8 th day with 6- OHDA injected in the third ventricle. Animals were killed 1 week post-lesion for immunohistochemistry studies as it was reported that progressive degeneration of mesencephalic DAergic cells produced by intraventricular injection of 6-OHDA reached the definitive lesion pattern at the end of the first week postinjection (Rodriguez et al. 2001). Our results indicated that aluminium enhanced the ability of 6-OHDA to cause lipid peroxidation and protein oxidation (except for PTC in ventral midbrain). In addition, the metal was able to increase the capacity of 6-OHDA to cause 153

SUMMARY<br />

values were atta<strong>in</strong>ed at 48 hours post-<strong>in</strong>jection for both TBARS and PCC, and at 24<br />

hours for PTC. Interest<strong>in</strong>gly, lower but significant <strong>in</strong>creases <strong>in</strong> <strong>oxidative</strong> <strong>stress</strong> levels<br />

were also seen <strong>in</strong> the contralateral side (ventral midbra<strong>in</strong> and striatum) exclud<strong>in</strong>g this<br />

zone as a control to determ<strong>in</strong>e neurochemical alterations caused by 6-OHDA <strong>in</strong> this<br />

experimental model <strong>of</strong> PD. At last and accord<strong>in</strong>g to the obta<strong>in</strong>ed results, we decided to<br />

establish the optimal time <strong>of</strong> 48 hours post-<strong>in</strong>jection for quantification <strong>of</strong> bra<strong>in</strong><br />

<strong>oxidative</strong> <strong>stress</strong> <strong>in</strong>dices when assess<strong>in</strong>g the <strong>oxidative</strong> potential <strong>of</strong> <strong>alum<strong>in</strong>ium</strong> <strong>in</strong> this<br />

experimental model <strong>of</strong> PD.<br />

152<br />

The second part <strong>of</strong> this thesis consisted <strong>in</strong> develop<strong>in</strong>g a dosage regimen <strong>of</strong><br />

<strong>alum<strong>in</strong>ium</strong> to rats which would guarantee a significant accumulation <strong>of</strong> this metal <strong>in</strong><br />

bra<strong>in</strong> areas and also to determ<strong>in</strong>e its precise distribution <strong>in</strong> the bra<strong>in</strong>. As it was<br />

previously suggested that <strong>alum<strong>in</strong>ium</strong> distribution depends on the animal species <strong>in</strong><br />

question and the chemical form <strong>of</strong> <strong>alum<strong>in</strong>ium</strong> adm<strong>in</strong>istered, we opted for two dist<strong>in</strong>ct<br />

adm<strong>in</strong>istration routes: oral and <strong>in</strong>traperitoneal. Sprague-Dawley rats were either daily<br />

i.p. <strong>in</strong>jected with <strong>alum<strong>in</strong>ium</strong> chloride (10 mg Al 3+ /kg/day) for 1 week, or given orally<br />

progressive <strong>in</strong>creas<strong>in</strong>g doses <strong>of</strong> <strong>alum<strong>in</strong>ium</strong> chloride (25, 50, 100 mg Al 3+ /kg/day)<br />

supplemented with citrate (89, 178, 356 mg/kg/day) dur<strong>in</strong>g 4 weeks. Our results showed<br />

that both adm<strong>in</strong>istration routes led to <strong>alum<strong>in</strong>ium</strong> accumulation. A greater and more<br />

significant <strong>in</strong>crease was noted <strong>in</strong> the group receiv<strong>in</strong>g <strong>alum<strong>in</strong>ium</strong> via <strong>in</strong>traperitoneal<br />

adm<strong>in</strong>istration for most bra<strong>in</strong> areas except <strong>in</strong> ventral midbra<strong>in</strong>. Distribution also varied<br />

with the adm<strong>in</strong>istration route used. In accordance to these results we resolved to use the<br />

<strong>in</strong>traperitoneal adm<strong>in</strong>istration route to clarify the bra<strong>in</strong> <strong>oxidative</strong> <strong>stress</strong> provoked by<br />

<strong>alum<strong>in</strong>ium</strong>.<br />

F<strong>in</strong>ally the third phase <strong>of</strong> this thesis was dedicated to determ<strong>in</strong>e the ability <strong>of</strong><br />

<strong>alum<strong>in</strong>ium</strong> to alter the oxidant status <strong>of</strong> specific bra<strong>in</strong> areas, such as cerebellum, ventral<br />

midbra<strong>in</strong>, cortex, hippocampus, and striatum. Male Sprague-Dawley rats were<br />

<strong>in</strong>traperitoneally adm<strong>in</strong>istered with <strong>alum<strong>in</strong>ium</strong> chloride (10 mg Al 3+ /kg/day) <strong>in</strong> sal<strong>in</strong>e<br />

for 10 days. As we demonstrated before, this dosage procedure was sufficient to <strong>in</strong>sure<br />

<strong>alum<strong>in</strong>ium</strong> accumulation <strong>in</strong> bra<strong>in</strong> areas. Animals were sacrificed 48 hours after lesion to<br />

perform lipid peroxidation and prote<strong>in</strong> oxidation studies because the peak for <strong>oxidative</strong>

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!